A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective study
Elizabeth Bancroft(Royal Marsden NHS Foundation Trust), Alan Donaldson(University Hospitals Bristol NHS Foundation Trust), Dorothy Halliday(Oxford University Hospitals NHS Trust), Nicholas Pachter(The University of Western Australia), Jonathan Hoffman(Birmingham Women's Hospital), Paul A. James(The Royal Melbourne Hospital), Helen Hanson(University of Exeter), Teresa Ramón y Cajal(Hospital de Sant Pau), Lyon Mascarenhas(Peter MacCallum Cancer Centre), Sarah Thomas(King's College London), Mohnish Suri(Nottingham University Hospitals NHS Trust), Jana McHugh(Institute of Cancer Research), Lynn Greenhalgh, Joanne McKinley(Peter MacCallum Cancer Centre), Ann-Britt Jones(Institute of Cancer Research), Eli Marie Grindedal(Oslo University Hospital), Nicola Poplawski(Royal Adelaide Hospital), Ashraf Azzabi(Newcastle upon Tyne Hospitals NHS Foundation Trust), Louise Izatt(Guy's and St Thomas' NHS Foundation Trust), Questa Karlsson(Institute of Cancer Research), Manuel R. Teixeira(Instituto Português de Oncologia Francisco Gentil), Lucy Side(Unknown), Mark N. Brook(Institute of Cancer Research), Rakefet Chen‐Shtoyerman(Kaplan Medical Center), Julian Barwell(London North West Healthcare NHS Trust), Finlay Macrae(The Royal Melbourne Hospital), Allan D. Spigelman(Cancer Institute of New South Wales), Nicola Nicolai(Fondazione IRCCS Istituto Nazionale dei Tumori), Astrid Stormorken(Oslo University Hospital), Saundra S. Buys(University of Utah), Marion Bartlett(London North West Healthcare NHS Trust), Sapna Syngal(Brigham and Women's Hospital), Chinedu Ukaegbu(Dana-Farber Cancer Institute), Lovise Mæhle(Unknown), Katie Snape(Institute of Cancer Research), D. Gareth Evans(Manchester Academic Health Science Centre), Camilla Huber(Birmingham Women's Hospital), Munaza Ahmed(Great Ormond Street Hospital), Jennifer Pope(Institute of Cancer Research), Angela F. Brady(London North West Healthcare NHS Trust), Brian T. Helfand(NorthShore University HealthSystem), Hannah Musgrave(Leeds Teaching Hospitals NHS Trust), Carole Brewer(Royal Devon and Exeter Hospital), Tessy Thomas(Princess Anne Hospital), Elizabeth Page(Institute of Cancer Research), Jeanette Rothwell(Manchester Academic Health Science Centre), Fiona Lalloo(Manchester Academic Health Science Centre), Natalie Taylor(Royal Marsden NHS Foundation Trust), Kai Ren Ong(Birmingham Women's Hospital), Susan Merson(Institute of Cancer Research)
Cited by 93
Related Papers
A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer
|Nature Genetics|2007|1.5k
Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2021|1.1k
Celecoxib for the Prevention of Sporadic Colorectal Adenomas
|New England Journal of Medicine|2006|1k